ROCHESTER, N.Y., November 12, 2025—CooperVision announced today that Jennifer Lambert, Vice President of Myopia Management & Cornea Care has been honored with a Silver Stevie® Award for Women in Business in the category of Female Executive of the Year, Consumer Products, More Than 2,500 Employees, and a Bronze Stevie® Award for Woman of the Year in Healthcare. The Stevie® Awards for Women in Business recognize exceptional female leaders whose innovation, vision, and achievements are shaping various industries around the world.
Lambert was awarded for her leadership in advancing childhood myopia management on a global scale. Under her guidance, CooperVision’s MiSight® 1 day contact lenses—the first FDA-approved soft contact lens proven to slow myopia progression in children—have expanded to more than 40 countries, with the most recent approval in Japan as the first and only soft contact lens approved for myopia control.*†1 She also spearheaded CooperVision’s partnership with the World Council of Optometry, resulting in the development and launch of the WCO CooperVision Myopia Management Navigator (myopianavigator.info). This partnership has inspired more than 70,000 eye care professionals (ECPs) across 217 organizations to make evidence-based myopia management the clinical standard of care.2,3,4
“Jennifer’s leadership and vision have been instrumental in advancing the global conversation surrounding myopia management,” said Jerry Warner, President, CooperVision. “Her efforts have expanded access, accelerated adoption,5 and inspired the next generation of care for children’s vision around the globe.”
The Female Executive of the Year category recognizes women who have made significant contributions to both their organizations or industry, while the Woman of the Year award honors women in any job title for their outstanding achievements and impact. Lambert was honored during the annual Stevie® Awards recognition dinner held on November 10 in New York City.
For more information about the Stevie® Awards for Women in Business and to view the full list of winners, please visit www.StevieAwards.com/Women.
###
* Compared to a single vision 1 day lens over a 3-year period.
† Indications for use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
1 Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. OVS 2019; 96(8):556-567.
2 Resolution: The standard of care for Myopia Management by Optometrists. World Council of Optometry. (2021, May 17). https://worldcouncilofoptometry.info/resolution-the-standard-of-care-for-myopia-management-by-optometrists.
3 Reshaping care: New myopia management guidance released. AOA. (2021, January 12). https://www.aoa.org/news/clinical-eye-care/diseases-and-conditions/new-myopia-management-guidance-released
4 American Academy of Ophthalmology Leads Global Initiative to address worldwide myopia epidemic. American Academy of Ophthalmology. (2020, November 11). https://www.aao.org/newsroom/news-releases/detail/academy-leads-initiative-to-address-myopia
5 CVI data on file, 2025. Internal MiSight® 1 day global wearer modeling estimates for the 12-month period of June 2024 to May 2025.
About CooperVision
CooperVision, a division of CooperCompanies (Nasdaq: COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, Calif., CooperCompanies has a workforce of more than 16,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit www.coopercos.com.
Media Contact
Maggie O’Donoghue, Counselor
McDougall Communications for CooperVision
Maggie@McDougallPR.com or +1-585-208-8534